Clinical studies with agents active on the 5-lipoxygenase pathway.
Where this comes from
- Record sourced from PubMed, PMID 7793535.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Leukotrienes may be considered asthmatic mediators. Compounds inhibiting their production and activity show promise in the treatment of asthma. Further clinical studies will determine the clinical usefulness of such agents.
Medical subject headings
- Asthma
- Lipoxygenase Inhibitors